Stockscreener 앱 받기
3.57
1.13%
0.04
전일 마감가:
$3.53
열려 있는:
$3.48
하루 거래량:
108.24K
Relative Volume:
0.64
시가총액:
$31.06M
수익:
-
순이익/손실:
$-30.98M
주가수익비율:
-0.2923
EPS:
-12.2116
순현금흐름:
$-31.84M
1주 성능:
-4.29%
1개월 성능:
+5.93%
6개월 성능:
-12.29%
1년 성능:
-53.73%
1일 변동 폭
$3.46
$3.60
1주일 범위
$3.46
$3.80
52주 변동 폭
$2.60
$14.68
Briacell Therapeutics Corp Stock (BCTX) Company Profile
명칭
Briacell Therapeutics Corp
전화
(604) 921-1810
주소
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Compare BCTX vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
3.57 | 34.19M | 0 | -30.98M | -31.84M | -12.21 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-02-14 | 개시 | H.C. Wainwright | Buy |
Briacell Therapeutics Corp 주식(BCTX)의 최신 뉴스
Why Did BriaCell Therapeutics (TSX:BCT) Surge 12.37% on 19 August 2026? - kalkine.ca
BriaCell (BCTX) Results Breakdown: Reported EPS Tops Expectations in the Current Update; After Earnings - vinanet.vn
BriaCell Therapeutics Stock Rises 3.19% as Phase 3 Breast Cancer Trial and Bria-IMT Progress Draw Investor Interest - kalkine.ca
BriaCell Therapeutics Stock: A Breast-Cancer Immunotherapy Nears Late-Stage Data - kalkine.ca
BCTX Q2 2026 Earnings: Narrower-Than-Expected Loss of -$2.58 Beats Estimates by 47.22%Revenue Recognition Risk - Vinanet
Briacell Therapeutics Corp (BCTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BCTXL Holds Steady at $0.85 as BriaCell Warrant Trades in Tight RangeVolume Nodes - Vinanet
BriaCell Therapeutics Corp (TSX:BCT) Shares Decline as Biotech Uncertainty, Funding Risks and Clinical Execution Concerns Pressure Sentiment - kalkine.ca
Enterprise value to EBIT forward of BriaCell Therapeutics Corp. – BOATS:BCTXL - TradingView
BriaCell Therapeutics Corp. (BCTXZ) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Briacell Therapeutics Corp (BCTX) Stock News Today - TradingKey
BCTX Q2 2026 Earnings: Narrower Loss Beats Estimates as Clinical Pipeline AdvancesRevenue Growth Outlook - vinanet.vn
BriaCell Receives FDA Clearance to Initiate Bria-PROS+ Clinical Study in Prostate Cancer - Investing News Network
BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer - The Manila Times
FDA clearance lets BriaCell test personalized prostate immunotherapy - Stock Titan
BriaCell Therapeutics (BCTX) Rises 3.86% to $3.5 as Immuno-Oncology Interest BuildsAnalyst Downgrade Signals - dars.gov.et
Why Did BriaCell Therapeutics Corp. (TSX:BCT) Stock Fall 5.49% on 31 July 2026? - kalkine.ca
BriaCell Therapeutics (BCTX) Slides 5.2% to $3.44 as Biotech Selling Pressure IntensifiesAscending Triangle - vinanet.vn
BriaCell Therapeutics Warrant (BCTXZ) Holds at $0.09 as Long-Dated Biotech Option Trades FlatUp Down Volume - dars.gov.et
BriaCell Therapeutics Corp Revenue Breakdown – TSX:BCT - TradingView
BriaCell Therapeutics Corp. Revenue Breakdown – BOATS:BCTXL - TradingView
Briacell Therapeutics Corp (BCTX) Institutional Confidence - TradingKey
Briacell Therapeutics Corp (BCTX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BCTX|Briacell Therapeutics Corp|Price:3.338|Chg%:-0.022 - TradingKey
BCTXL Slips 7.87%: Support Test for BriaCell WarrantModified Schiff - vinanet.vn
Briacell Therapeutics Corp (BCTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Briacell Therapeutics Corp (BCTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Briacell Therapeutics Corp (BCTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BriaCell Therapeutics Market Sentiment - Benzinga España
Briacell Therapeutics Corp (BCTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Briacell Therapeutics Corp (BCTX) Income Statement - TradingKey
BCTX|Briacell Therapeutics Corp|Price:3.525|Chg%:-0.055 - TradingKey
Briacell Therapeutics Corp (BCTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BCTX Q2 2026 Earnings: Narrower-than-expected loss as clinical-stage biotech advances pipelineEarnings Preview - Vinanet
TradingKey - TradingKey
BriaCell Therapeutics Corp. Revenue Breakdown – NASDAQ:BCTXL - TradingView
BriaCell Therapeutics Corp. Revenue Breakdown – NASDAQ:BCTXZ - TradingView
BCTX Q2 2026 Earnings: Narrower Loss Beats Estimates Amid Drug Development ProgressEarnings Season Outlook - vinanet.vn
BriaCell Therapeutics Corp Revenue Breakdown – MUN:8BT - TradingView
BCTX|Briacell Therapeutics Corp|Price:3.580|Chg%:-0.140 - TradingKey
BriaCell Therapeutics Warrant (BCTXL) Holds Steady at $0.89 as Support and Resistance Levels Come into FocusHidden Order - dars.gov.et
Price to earnings forward of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Why Briacell Therapeutics Corp stock is sliding today - Wealth Awesome
What's Going On With Briacell Therapeutics Corp Stock Monday? - Wealth Awesome
BriaCell Therapeutics Warrants (BCTXZ) Spike 9.32% as Shares Test Key Support at $0.10Sector ETF Flow - dars.gov.et
Is CRA International’s New Bria-IMT Role Quietly Redefining Its Healthcare Moat and Pricing Power (CRAI)? - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
BriaCell (BCTX) Expands Phase 3 Study with New Clinical Site - GuruFocus
What Does BriaCell's Latest Offering Mean for Shareholders - Kavout | AI
Briacell Therapeutics Corp. - Menafn
Stocks in play: BriaCell Therapeutics Corp. - Barchart.com
Briacell Therapeutics Corp (BCTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.86%
0.31%
자본화:
|
볼륨(24시간):